Author/Creator: Elgart, Anna - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Elgart, Anna

1. A Thorough QT/QTc Study With Laquinimod, a Novel Immunomodulator in Development for Multiple Sclerosis and Huntington Disease. Issue 1 (22nd May 2018)

Authors:: Spiegelstein, Ofer; Mimrod, Dorit; Rabinovich, Laura; Eyal, Eli; Sprenger, Craig; Elgart, Anna; Samara, Emil; Morganroth, Joel
Journal:: Clinical pharmacology in drug development
Issue:: Volume 8:Issue 1(2019)
Page Start:: 49
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. The Effect of CYP3A Induction and Inhibition on the Pharmacokinetics of Laquinimod, a Novel Neuroimmunomodulator. Issue 8 (1st April 2020)

Authors:: Elgart, Anna; Greenblatt, David J.; Loupe, Pippa S.; Zur, Arik A.; Weiss, Sivan; Mimrod, Dorit; Spiegelstein, Ofer
Journal:: Clinical pharmacology in drug development
Issue:: Volume 9:Issue 8(2020)
Page Start:: 1015
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Population Pharmacokinetic Modeling and Simulation of TV‐46000: A Long‐Acting Injectable Formulation of Risperidone. Issue 7 (4th March 2022)

Authors:: Perlstein, Itay; Merenlender Wagner, Avia; Gomeni, Roberto; Lamson, Michael; Harary, Eran; Spiegelstein, Ofer; Kalmanczhelyi, Attila; Tiver, Ryan; Loupe, Pippa; Levi, Micha; Elgart, Anna
Journal:: Clinical pharmacology in drug development
Issue:: Volume 11:Issue 7(2022)
Page Start:: 865
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Pharmacokinetics and safety of single and multiple doses of rasagiline in healthy Japanese and caucasian subjects. Issue 3 (21st October 2018)

Authors:: Elgart, Anna; Rabinovich‐Guilatt, Laura; Eyal, Eli; Gross, Aviva; Spiegelstein, Ofer
Journal:: Basic & clinical pharmacology & toxicology
Issue:: Volume 124:Issue 3(2019)
Page Start:: 273
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Impact of dosing regimen of custirsen, an antisense oligonucleotide, on safety, tolerability and cardiac repolarization in healthy subjects. (22nd June 2015)

Authors:: Rabinovich‐Guilatt, Laura; Elgart, Anna; Erisson, Lavi; Willsie, Sandra K.; Tessler, Shoshi; Barnett‐Griness, Ofra; Pande, Amitkumar; Spiegelstein, Ofer
Journal:: British journal of clinical pharmacology
Issue:: Volume 80:Number 3(2015:Sep.)
Page Start:: 436
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. A population pharmacokinetic meta‐analysis of custirsen, an antisense oligonucleotide, in oncology patients and healthy subjects. (2nd May 2017)

Authors:: Edwards, Alena Y.; Elgart, Anna; Farrell, Colm; Barnett‐Griness, Ofra; Rabinovich‐Guilatt, Laura; Spiegelstein, Ofer
Journal:: British journal of clinical pharmacology
Issue:: Volume 83:Number 9(2017)
Page Start:: 1932
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗